• Zealand Pharma average return on tangible equity for 2023 was -104.36, a 32.98% decline from 2022.
• Zealand Pharma average return on tangible equity for 2022 was -155.72, a 101.4% decline from 2021.
• Zealand Pharma average return on tangible equity for 2021 was -77.32, a 55.11% increase from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.